Medicus Pharma Valuation
MDCX Stock | USD 2.54 0.44 20.95% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Medicus Pharma secures a last-minute Real Value of $2.92 per share. The latest price of the firm is $2.54. Our model forecasts the value of Medicus Pharma from analyzing the firm fundamentals such as Current Valuation of 26.78 M, net income of (138.89 K), and Price To Book of 4.65 X as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Medicus Pharma's price fluctuation is out of control at this time. Calculation of the real value of Medicus Pharma is based on 3 months time horizon. Increasing Medicus Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Medicus Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medicus OTC BB Equity. However, Medicus Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.54 | Real 2.92 | Hype 2.54 | Naive 1.22 |
The intrinsic value of Medicus Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medicus Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medicus Pharma Ltd helps investors to forecast how Medicus otc bb equity's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medicus Pharma more accurately as focusing exclusively on Medicus Pharma's fundamentals will not take into account other important factors: Medicus Pharma Total Value Analysis
Medicus Pharma Ltd is now forecasted to have valuation of 26.78 M with market capitalization of 30.01 M, debt of 103.23 K, and cash on hands of 1.22 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Medicus Pharma fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
26.78 M | 30.01 M | 103.23 K | 1.22 K |
Medicus Pharma Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Medicus suggests not a very effective usage of assets in November.Medicus Pharma Profitability Analysis
Net Loss for the year was (138.89 K) with profit before overhead, payroll, taxes, and interest of 0.About Medicus Pharma Valuation
Our relative valuation model uses a comparative analysis of Medicus Pharma. We calculate exposure to Medicus Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medicus Pharma's related companies.Additional Tools for Medicus OTC BB Equity Analysis
When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.